News Releases

News Releases

Date Title
Sep 8, 2020 Sesen Bio to Provide Business Update at the H. C. Wainwright 22nd Annual Global Investment Conference
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Sep. 8, 2020-- Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced it will be featured as a presenting company at the H. C.
Aug 10, 2020 Sesen Bio Reports Second Quarter 2020 Financial Results and Business Update
On-track to complete BLA submission in the US in the fourth quarter of 2020 Entered into a license agreement with Qilu Pharmaceutical for the development and commercialization of Vicineum™ in Greater China with $12M upfront payment Manufacturing of PPQ campaign drug substance batches has been
Aug 5, 2020 Sesen Bio to Present Regulatory and Business Development Update at the Canaccord Genuity 40th Annual Growth Conference
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Aug. 5, 2020-- August 5, 2020 – Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced it will be featured as a presenting company at the Canaccord Genuity
Jul 31, 2020 Sesen Bio announces an exclusive license agreement with Qilu Pharmaceutical for the development and commercialization of Vicineum™ in Greater China
Sesen to receive $12 million upfront and $23 million in potential regulatory and tech transfer milestone payments Sesen eligible to receive royalties on net sales in China Sesen to host conference call Friday, July 31 st at 8:00 a.m. EDT CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jul.
Jul 30, 2020 Sesen Bio to Host Conference Call to Provide OUS Business Update
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jul. 30, 2020-- Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Company management will host a conference call and webcast on Friday, July 31,
May 26, 2020 Sesen Bio to Present at the Jefferies Virtual Healthcare Conference
CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 26, 2020-- Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced it will be featured as a presenting company at the Jefferies Virtual Healthcare
May 11, 2020 Sesen Bio Reports First Quarter 2020 Financial Results and Meaningful Progress Towards Demonstrating Analytical Comparability
Manufacturing and release testing of the Fujifilm pre-PPQ batch completed successfully Positive Interactions with EMA on Regulatory Pathway for Vicinium ® in Europe Market research conducted in 1Q 2020 supports Urologists prefer Vicinium to Keytruda ® CAMBRIDGE, Mass.
May 7, 2020 Sesen Bio Reports Positive Interactions with EMA on Regulatory Pathway for Vicinium®
No additional clinical trials were requested by the CHMP for submission of Vicinium marketing authorization application Anticipated submission of marketing authorization application in early 2021 CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 7, 2020-- Sesen Bio (Nasdaq: SESN), a late-stage clinical
May 4, 2020 Sesen Bio to Host Conference Call to Review First Quarter Financial Results and to Provide Operational Update Highlighting Positive Progress Towards Demonstrating Analytical Comparability
CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 4, 2020-- Sesen Bio (Nasdaq: SESN ), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Company management will host a conference call and webcast on Monday, May 11,
Mar 16, 2020 Sesen Bio Reports Fourth Quarter and Full-Year 2019 Financial Results
Company on track to complete Vicinium ® BLA submission in the second half of 2020 with potential approval in first half of 2021 New market research supports large commercial opportunity CAMBRIDGE, Mass. --(BUSINESS WIRE)-- Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted
Displaying 1 - 10 of 13
Top